Richard IJzerman

Research output

Research output per year 1995 2010 2014 2016 2017 2018 2021 2022 2023

• 98 Article
• 15 Meeting Abstract
• 7 Comment/Letter to the editor
• 2 Chapter
• 4 More
  • 2 Letter
  • 2 Review article

Research output per year

Research output per year

Search results

• 2019

  Erratum: SGLT2 inhibitors in combination therapy: From mechanisms to clinical considerations in type 2 diabetes management. (Diabetes Care (2018) 41 (1543–1556) DOI: 10.2337/dc18-0588)

  van Baar, M. J. B., van Ruiten, C. C., Muskiet, M. H. A., van Bloemendaal, L., IJzerman, R. G. & van Raalte, D. H., 1 Oct 2019, In: Diabetes Care. 42, 10, p. 2015 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2018

  Effect van nieuwe diabetesmedicatie op mortaliteit

  Translated title of the contribution: Effect of new diabetes medication on mortalityChen, W. & IJzerman, R., 1 Jan 2018, In: Nederlands Tijdschrift voor Geneeskunde. 162, 32, D3099.

  Research output: Contribution to journal › Comment/Letter to the editor › Professional

• Potential of butyrate to influence food intake in mice and men

  Fluitman, K. S., Wijdeveld, M., Nieuwdorp, M. & IJzerman, R. G., 2018, In: Gut. 67, 7, p. 1203-1204

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  26 Citations (Scopus)
• 2017

  Overbehandeling van ouderen met diabetes type 2

  Translated title of the contribution: Overtreatment of elderly people with type 2 diabetesLinger-Wever, S. & Ijzerman, R. G., 2017, In: Nederlands Tijdschrift voor Geneeskunde. 161, 21

  Research output: Contribution to journal › Comment/Letter to the editor › Professional
• 2009

  Two cases of antiruthenium antibody interference in Modular free thyroxine assay

  Heijboer, A. C., Ijzerman, R. G., Bouman, A. A. & Blankenstein, M. A., 2009, In: Annals of clinical biochemistry. 46, Part 3, p. 263-264

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  20 Citations (Scopus)
• 2008

  Gecombineerde uitkomstmaten in klinische trials zijn vaak misleidend

  Translated title of the contribution: Composite end points in clinical trials are often misleadingIjzerman, R. G., 5 Jan 2008, In: Nederlands Tijdschrift voor Geneeskunde. 152, 1, p. 55-56 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2005

  Genetic and environmental origins of the association between birth weight and cardiovascular risk factors

  Ijzerman, R. G., 12 Dec 2005, In: Journal of thrombosis and haemostasis. 3, 6, p. 1141-1142 2 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
  2 Citations (Scopus)